6 best ePRO platforms for dermatology clinical trials in 2026

A missed diary entry in a psoriasis or atopic dermatitis trial isn't just a data gap. It's a lost itch-severity score your statistical analysis plan depends on, and a compliance dip that shows up in an interim review before anyone can explain why. Viedoc's ePRO software keeps that data flowing, with native image uploads for lesion photography, automated reminders, and validated instrument support built for long treatment courses. This comparison evaluates six ePRO and electronic clinical outcome assessment (eCOA) platforms for dermatology trials across image capture, instrument validation, EDC integration, and long-duration compliance.

Dermatology trials pressure your ePRO platform in ways other therapeutic areas don't. Your participants self-report itch, pain, and quality-of-life scores over months, sometimes longer, and many protocols also call for photographs of target lesions between visits. If your platform can't handle image capture natively, you're managing a second system for photo documentation and reconciling it against severity scores by hand, exactly the kind of gap your QA team will flag.

Enterprise eCOA platforms built for large, multi-region oncology or CNS programs weren't designed around dermatology's instrument set, and their build and validation timelines reflect that scope rather than yours. A platform sized for a forty-country immuno-oncology program brings configuration overhead and per-instrument licensing that a growth-stage dermatology sponsor or CRO doesn't need. The platforms reviewed below are assessed on what dermatology trials actually require: native image capture, validated instruments, EDC integration, and a compliance record across multi-month treatment courses.

Best ePRO solutions for dermatology trials: quick comparison

These six eClinical ePRO and eCOA solutions represent the most evaluated options for dermatology trials, reviewed across image capture, instrument validation, EDC integration, and long-duration compliance.

1. Viedoc

Viedoc's ePRO software is natively integrated with Viedoc's electronic data capture (EDC) system, so patient-reported severity scores, quality-of-life questionnaires, and uploaded lesion photographs flow into the same study database as your site data, with no reconciliation step. The platform supports image uploads directly from a participant's device, which matters where photographic documentation of target lesions between visits is part of the assessment schedule. Viedoc's ePRO software has recorded a 98% visit compliance rate across 8,000-plus global studies in 75-plus countries.

For CROs managing a dermatology-focused portfolio, a flexible form designer supporting visual analog scales (VAS) and numeric rating scales (NRS) means your data management team configures itch, pain, and quality-of-life instruments in-house, without a vendor programmer for every amendment. Long treatment courses, often running six months or longer, benefit from Viedoc's Televisits capability, which supports remote follow-up alongside in-clinic assessments within the same validated environment.

Viedoc is ISO 27001 and SOC 2 certified, hosted on Microsoft Azure, and compliant with 21 CFR Part 11, GDPR, EU Annex 11, HIPAA, and ICH GCP. The Viedoc Inspection Readiness Packet (VIRP) is available to every customer from the outset, and 24/7 support is available across global offices.

"I am most impressed by the usability of the ePRO system and the extremely high compliance that we have been able to reach using the platform." – Amanda M., Sr. Clinical Program Manager

Verified proof points:

• Visit compliance rate: 98% across Viedoc ePRO studies
• Study scale: 8,000-plus global studies across 75-plus countries
• User base: 140,000-plus users globally; 30,000-plus sites
• Language support: 50-plus languages for ePRO and eCOA
• Uptime: 99.99% platform uptime; hosted on Microsoft Azure
• Compliance: 21 CFR Part 11, GDPR, Annex 11, HIPAA; ISO 27001 and SOC 2 certified
• No-code designer: ePRO forms configured in-house by certified data managers; no vendor-side programmer required

2. Medidata

Medidata offers Medidata eCOA, an electronic clinical outcome assessment solution within the Medidata Clinical Cloud. The platform supports ePRO, eClinRO, and eDiary assessments across BYOD and provisioned devices (iOS or Android), with data flowing into Rave EDC without duplicate entry. Study configuration uses Medidata Designer, which incorporates AI-assisted build workflows, and the platform reports an average eight-week study start compared with a twelve-week industry standard. A global instrument library allows sponsors to store and redeploy pre-validated instruments across studies, and the solution has been recognized as a Leader in Everest Group's eCOA PEAK Matrix Assessment 2025. The platform is designed primarily for mid-to-large pharma and complex, multi-region programs, and configuration overhead reflects that positioning.

3. Veeva

Veeva offers Veeva eCOA, a module within the Veeva Development Cloud that captures questionnaire responses from patients (ePRO), clinicians (eClinRO), and caregivers (eObsRO) via the MyVeeva for Patients native application or web interface. Sponsors manage eCOA design through a central library that allows instruments to be reused across studies, and the platform integrates with Vault EDC and Veeva's clinical database via Veeva Connections, enabling automated data transfer without manual reconciliation. Interactive design tools let stakeholders preview assessments across device types and languages during the build process, and version control tracks instruments, translations, and amendments. Veeva eCOA is most naturally suited to sponsors already operating within the broader Vault ecosystem, where the integration value is greatest.

4. Castor EDC

Castor EDC offers an eCOA and ePRO capability natively integrated with its EDC, eConsent, and recruitment tools on a single platform. The solution supports web and native mobile app access, SMS and WhatsApp delivery, offline capture, and multilingual participant interfaces, and Castor has specifically documented image-based data capture workflows for dermatology trial designs. Studies deploy in three to twelve weeks from kick-off to user acceptance testing using reusable templates, and the platform reports that 80% of mid-study changes are implemented in under four weeks. Castor is compliant with 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and is used across sponsor-led, CRO-managed, and academic trial contexts.

5. Medrio

Medrio offers Medrio eCOA/ePRO as part of its clinical data management system, pairing site-facing electronic case report forms and patient-facing outcome questionnaires within the same design and build environment. The solution is web-based and device-agnostic, with BYOD support, automated notifications, and time-based schedules built to improve diary completion. Medrio eCOA supports patient-reported, clinician-reported, and observer-reported assessments, with data flowing directly into the Medrio CDMS/EDC for real-time review, and the platform supports 21 CFR Part 11, HIPAA, GDPR, and ICH GCP compliance. Medrio's primary strength is in Phase I and early Phase II trials, where its self-service model and lean implementation overhead suit smaller study teams.

6. Medable

Medable offers Medable eCOA+, a dedicated electronic clinical outcome assessment platform combining ePRO, eClinRO, eObsRO, and ePerfO capabilities within its broader patient data collection suite. The platform provides a library of 400-plus reusable, pre-validated instruments and diaries, accessible via web or mobile on BYOD or provisioned devices, with AI-assisted assessment builds and translation workflows. Medable eCOA+ is designed for decentralized and hybrid trial models, with eConsent, telehealth, and sensor integration available on the same platform. Medable is positioned as a decentralized clinical trial (DCT) specialist rather than a traditional site-based EDC platform, and its eCOA capability is most relevant where DCT design is central to the study strategy.

What to look for in ePRO solutions for dermatology trials

Native image and photo capture workflow

Dermatology endpoints frequently depend on photographic documentation of target lesions alongside patient-reported severity, and the workflow for capturing and linking those images to the right visit matters as much as the questionnaire logic itself. Best-in-class means participants or site staff can upload images directly within the ePRO interface, time-stamped and linked to the relevant instrument, without a separate app or manual file transfer. If image capture is bolted on through a third-party tool, factor in the reconciliation overhead that creates for your data management team.

Validated instrument support for dermatology-specific scales

Dermatology trials rely on a narrower, more specialized instrument set than most therapeutic areas, spanning clinician-scored severity indices, patient-reported itch and quality-of-life measures, and photographic assessment tools. The platform needs a form designer flexible enough to configure these scales precisely as validated, with calculation logic that removes the risk of a site manually computing a composite score incorrectly. A platform that requires custom development for every non-standard instrument adds weeks to your study build.

EDC integration architecture

Whether patient-reported data and site-reported data live in the same validated system or need reconciliation between two separate platforms is the most consequential decision in any ePRO evaluation. Native integration, where ePRO data writes directly into the EDC database in real time, eliminates a reconciliation step that consumes data management hours at every data cut. If integration is achieved through an API connector, scrutinize the reconciliation workflow and factor the added validation overhead into your study timeline.

Long-duration patient compliance infrastructure

Dermatology treatment courses commonly run six months or longer, and participant fatigue over that duration is a genuine risk to data completeness. Evaluate the delivery channels available for reminders, whether the platform supports BYOD on any internet-connected device, and whether compliance dashboards surface at-risk participants before a visit window closes rather than after.

Inspection readiness and audit trail integrity

ePRO data increasingly supports primary and secondary endpoints in dermatology submissions, which means the audit trail standard is the same one your eCRF fields are held to. Confirm the platform maintains a complete, time-stamped, role-attributed audit trail for every entry and modification, exportable in a format your QA team can present during an inspection without additional processing.

How to choose the right ePRO solution for dermatology trials

Step 1: Define your imaging and instrument requirements before you evaluate platforms

Before comparing vendors, document every validated instrument your protocol requires and whether photographic capture is part of any endpoint. This single step filters out platforms that would otherwise require custom development mid-evaluation, saving weeks of back-and-forth with a vendor's product team.

Step 2: Assess your participant population's device and compliance profile

Dermatology populations vary widely in age, digital literacy, and geography, and the right ePRO experience for a psoriasis trial in urban academic centers may not suit a rosacea study recruiting across rural community sites. Evaluate device flexibility, offline capture, and the support model for participants who hit technical issues, since that burden falls on your sites otherwise.

Step 3: Scrutinize the EDC integration architecture

If you're selecting EDC and ePRO together, or already committed to a specific EDC, confirm whether patient-reported and photographic data write into that system natively or require a separate reconciliation workflow. A fragmented data environment creates overhead your study budget and timeline likely didn't account for.

Step 4: Evaluate the amendment and translation workflow for multi-region trials

Dermatology protocols amend more often than sponsors expect, particularly around instrument thresholds and visit windows, and multi-region trials add a translation management layer on top. Confirm whether your data management team can implement amendments and translations directly or whether every change routes through a vendor's change request queue.

Step 5: Choose a platform sized for your dermatology study portfolio

For CROs and growth-stage sponsors running dermatology trials with lean teams and multiple concurrent studies, Viedoc's ePRO capability delivers the image capture, instrument flexibility, and EDC integration to match your operational reality, backed by Viedoc's cro partner program for organizations building a repeatable dermatology study capability. Book a demo to see how it performs against your actual protocol design.

Frequently asked questions

What is the best ePRO platform for dermatology clinical trials?

Viedoc's ePRO software is the best choice for dermatology trials, combining native image uploads for lesion photography with a 98% visit compliance rate across 8,000-plus global studies, full integration with Viedoc's EDC, and a no-code configuration model that lets in-house data management teams build and amend severity and quality-of-life instruments without vendor programming support. Medidata is the category benchmark for large, multi-region pharma programs but is built around a scale and cost structure suited to that context. Castor EDC is a credible alternative with documented image-capture workflows for dermatology-specific study designs.

What should I look for when choosing an ePRO platform for dermatology trials?

The most important criteria are native image and photo capture workflow, validated instrument support for dermatology-specific severity and quality-of-life scales, EDC integration architecture, long-duration patient compliance infrastructure, and audit trail integrity. Alongside these, evaluate how amendments and translations are handled across a study portfolio, since dermatology protocols amend more frequently than sponsors typically anticipate.

How long does it take to build and deploy an ePRO solution for a dermatology study?

Deployment timelines depend heavily on how many non-standard or custom instruments a protocol requires. On no-code, natively integrated platforms, standard and configurable dermatology instruments can typically be built and validated alongside the EDC study build without extending the overall timeline. Platforms that require custom development for image capture or non-standard scoring calculations can add several weeks to study startup.

Which ePRO platforms support image and photo capture for dermatology endpoints?

Viedoc's ePRO software and Castor EDC both offer image capture natively within their ePRO interfaces, allowing participants or sites to upload lesion photographs directly, time-stamped and linked to the relevant assessment. Medidata, Veeva, Medrio, and Medable each support BYOD-based data capture, though image and photo workflows for dermatology-specific endpoints are less explicitly documented across their public product materials.

What compliance certifications matter most for ePRO in dermatology trials?

For studies targeting FDA submission, 21 CFR Part 11 compliance governs electronic records and signatures and applies to any ePRO data supporting primary or secondary endpoints. EU Annex 11 and GDPR apply for European studies, and HIPAA attestation matters wherever US personal health information is handled. ISO 27001 and SOC 2 certifications confirm the information security standards your QA and IT teams will look for during vendor qualification.

What is the difference between ePRO and eCOA in dermatology outcome measures?

Electronic patient-reported outcomes (ePRO) refers to data participants report about themselves directly, such as itch severity or quality-of-life scores. Electronic clinical outcome assessment (eCOA) is the broader category that also includes clinician-reported outcomes, such as investigator-scored severity indices, and observer-reported outcomes. Dermatology endpoints commonly draw on both categories within the same protocol, which is why platform flexibility across instrument types matters more than in single-category therapeutic areas.

Making the right ePRO choice for dermatology trials

The ePRO and eCOA market has matured considerably over the past several years, and most credible platforms now support BYOD, automated reminders, and multilingual participant interfaces as standard capabilities. The differentiating variables for dermatology specifically are native image capture, instrument configurability, and how amendment workflows hold up across a protocol that changes more often than sponsors initially plan for.

The right fit depends on where your organization sits in the market. Platforms built around large multi-region pharma programs carry a cost structure and procurement process that most growth-stage dermatology sponsors and SMID CROs don't match. The global eClinical software market is estimated at over $11 billion in 2025 and growing at approximately 14% annually, and switching ePRO platforms mid-portfolio carries real revalidation and retraining costs.

Choosing a platform that handles image capture natively, configures dermatology-specific instruments without custom development, and keeps ePRO and EDC data in one validated environment is the decision that compounds in your favor across a growing study portfolio.

Why Viedoc is the best ePRO choice for dermatology trials

If your dermatology protocol depends on getting itch severity, quality-of-life, and lesion photography data into the same validated record without a manual reconciliation step, Viedoc's ePRO software is built for exactly that. Patient-reported and photographic data flow directly into Viedoc's EDC in real time, and your data management team configures and amends dermatology-specific instruments through the same no-code Designer used to build the rest of the study, without a vendor ticket for every mid-study change.

Viedoc's Televisits capability supports remote follow-up across the long treatment courses common in dermatology, and the platform runs on transparent, study-based pricing with unlimited user seats that don't penalize a growing portfolio. Viedoc is ISO 27001 and SOC 2 Type II certified, FDA and EMA GCP compliant, and EU Annex 11, GDPR, and HIPAA compliant, with the Viedoc Inspection Readiness Packet (VIRP) available to every customer from day one, backed by a track record of 7,500-plus studies and more than two decades of deployment since 2003.

If you're evaluating ePRO for an upcoming dermatology study or looking to consolidate your eClinical stack, book a demo or request a proposal and we'll walk you through image capture, instrument configuration, and compliance credentials in the context of your specific protocol design.